Buy Aurobindo Pharma on declines, says PN Vijay, Portfolio Manager.
Vijay told CNBC-TV18, "Aurobindo Pharma has had a huge run. I remember it made a low in the middle of May last year of something like Rs 110 or so and see where it is now. On the other hand Rs 110 was a very steep fall from double that amount.”
He further added, “One has to remember we are talking about a very volatile animal here. The news is good. The business model is good. I think there are a couple of corporate governance issues, which one needs to sort of mildly worry about when it comes to the stock. But I think the slumber sometimes happens especially in a stock which has been going all over the place in the last 24 months if you see the stock charts. So I would probably buy this on a decline. I think it is now into a very long-term uptrend."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.